DE3406837A1 - Arteriosklerose-arzneimittel und -prophylaktikum - Google Patents
Arteriosklerose-arzneimittel und -prophylaktikumInfo
- Publication number
- DE3406837A1 DE3406837A1 DE19843406837 DE3406837A DE3406837A1 DE 3406837 A1 DE3406837 A1 DE 3406837A1 DE 19843406837 DE19843406837 DE 19843406837 DE 3406837 A DE3406837 A DE 3406837A DE 3406837 A1 DE3406837 A1 DE 3406837A1
- Authority
- DE
- Germany
- Prior art keywords
- diltiazem
- treatment
- medicament
- arteriosclerosis
- prophylaxis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58031515A JPS59157021A (ja) | 1983-02-25 | 1983-02-25 | 動脈硬化症予防治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3406837A1 true DE3406837A1 (de) | 1984-08-30 |
DE3406837C2 DE3406837C2 (sv) | 1990-12-20 |
Family
ID=12333337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19843406837 Granted DE3406837A1 (de) | 1983-02-25 | 1984-02-24 | Arteriosklerose-arzneimittel und -prophylaktikum |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS59157021A (sv) |
BE (1) | BE899000A (sv) |
CH (1) | CH658389A5 (sv) |
DE (1) | DE3406837A1 (sv) |
DK (1) | DK163712C (sv) |
FR (1) | FR2541577B1 (sv) |
GB (1) | GB2135192B (sv) |
HK (1) | HK45389A (sv) |
IT (1) | IT1178863B (sv) |
NL (1) | NL8400548A (sv) |
SE (1) | SE8400971L (sv) |
SG (1) | SG21189G (sv) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778791A (en) * | 1986-05-16 | 1988-10-18 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical composition for improving constitution of lipids in blood |
JPS63107925A (ja) * | 1986-05-23 | 1988-05-12 | Tanabe Seiyaku Co Ltd | 動脈硬化症予防・治療剤 |
JP2658783B2 (ja) * | 1992-12-10 | 1997-09-30 | 田辺製薬株式会社 | 抗動脈硬化剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562257A (en) * | 1967-10-28 | 1971-02-09 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
GB1236467A (en) * | 1967-10-28 | 1971-06-23 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
-
1983
- 1983-02-25 JP JP58031515A patent/JPS59157021A/ja active Granted
-
1984
- 1984-02-21 NL NL8400548A patent/NL8400548A/nl not_active Application Discontinuation
- 1984-02-22 SE SE8400971A patent/SE8400971L/sv unknown
- 1984-02-24 DE DE19843406837 patent/DE3406837A1/de active Granted
- 1984-02-24 FR FR8402895A patent/FR2541577B1/fr not_active Expired
- 1984-02-24 CH CH925/84A patent/CH658389A5/de not_active IP Right Cessation
- 1984-02-24 BE BE0/212448A patent/BE899000A/fr not_active IP Right Cessation
- 1984-02-24 IT IT8467183A patent/IT1178863B/it active
- 1984-02-24 DK DK103084A patent/DK163712C/da not_active IP Right Cessation
- 1984-02-27 GB GB08405060A patent/GB2135192B/en not_active Expired
-
1989
- 1989-04-07 SG SG211/89A patent/SG21189G/en unknown
- 1989-06-07 HK HK453/89A patent/HK45389A/xx not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
Münchner Medizinische Wochenschrift, 123, 1981, S. 15-21 * |
PSCHYREMBEL, W.: Klinisches Wörterbuch, 1982, S. 86-87 * |
Also Published As
Publication number | Publication date |
---|---|
DK103084A (da) | 1984-08-26 |
JPS59157021A (ja) | 1984-09-06 |
CH658389A5 (de) | 1986-11-14 |
GB2135192B (en) | 1986-10-22 |
IT1178863B (it) | 1987-09-16 |
JPS6358809B2 (sv) | 1988-11-17 |
GB8405060D0 (en) | 1984-04-04 |
BE899000A (fr) | 1984-06-18 |
IT8467183A1 (it) | 1985-08-24 |
FR2541577A1 (fr) | 1984-08-31 |
GB2135192A (en) | 1984-08-30 |
SE8400971L (sv) | 1984-08-26 |
DK163712B (da) | 1992-03-30 |
SG21189G (en) | 1990-01-26 |
SE8400971D0 (sv) | 1984-02-22 |
DE3406837C2 (sv) | 1990-12-20 |
HK45389A (en) | 1989-06-16 |
IT8467183A0 (it) | 1984-02-24 |
NL8400548A (nl) | 1984-09-17 |
DK103084D0 (da) | 1984-02-24 |
DK163712C (da) | 1992-08-31 |
FR2541577B1 (fr) | 1987-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0241809B1 (de) | Synergistische Kombination von Amantadin und Selegilin | |
DE2911670A1 (de) | Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen | |
EP0180785B1 (de) | Arzneimittel, enthaltend eine Kombination von Nitrendipin mit Enalapril, und Verfahren zu seiner Herstellung | |
DE3639378C2 (sv) | ||
AT389998B (de) | Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung | |
DE68915269T2 (de) | Polyvalentes entzündungshemmendes mittel. | |
DE2514335C3 (de) | Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung | |
DE2530862C2 (de) | Verwendung von Uridin-5'-diphosphat zur Verhütung und Behandlung von Alkoholismus | |
EP0224810B1 (de) | Antihypertensives Kombinationspräparat | |
CH660556A5 (de) | Therapeutische zubereitung zur behandlung von kardiovaskulaeren krankheiten. | |
DE69828390T2 (de) | Antikrebs-zusammensetzung | |
DE69308762T2 (de) | Behandlung des Muskulschwunds | |
DE3035494A1 (de) | Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels | |
DE3406837C2 (sv) | ||
DE60207442T2 (de) | VERWENDUNG EINER KOMBINATIONSZUSAMMENSETZUNG BESTEHEND AUS PROPIONYL L-CARNITIN UND WEITEREn WIRKSTOFFEn ZUR BEHANDLUNG DER EREKTILEN DYSFUNKTION | |
EP0207193A2 (de) | Synergistische Kombination von Flupirtin und 4-Acetamido-phenol | |
DE4029747C2 (de) | Verwendung von Hexadecylphosphocholin zur Behandlung von Psoriasis-Erkrankungen | |
DE69004529T2 (de) | Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen. | |
DE2161588C3 (de) | Mittel zur Behandlung von Hyperlipoproteinämien | |
WO1998058639A1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
DE3419425A1 (de) | Verwendung von d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-on als arzneimittel zur bekaempfung der hypolipidaemie | |
DE3780702T2 (de) | Verwendung von etodolac zur senkung des blutgehalts an harnsaeure. | |
DE69909395T2 (de) | Zusammensetzung mit ketanserin und carnitin zur behandlung von crps | |
DE1963223A1 (de) | Mittel zur Behandlung von Virusinfektionen | |
DE3410850A1 (de) | Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |